Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Emergent BioSolutions Inc. publishes a filing, an earnings call transcript or a press release.

Get EBS alerts

About Adam Havey

Adam Havey is recorded as COO at Emergent BioSolutions Inc. (EBS). The proxy statement of Emergent BioSolutions Inc. reports total compensation of $2,010,487 for Adam Havey in fiscal 2023, including a base salary of $557,966. Disclosed compensation is on record for 7 fiscal years. Adam Havey has spoken on 1 earnings call across 1 company, most recently for Emergent BioSolutions Inc. on November 4, 2021. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.

Adam Havey on recent calls

“Just as a reminder, the chikungunya virus is transmitted by mosquitoes, similar to malaria and Zika. The disease can lead to both acute and chronic symptoms, somewhat akin to Lyme disease, which highlights the importance of vaccination.”
COO, Emergent BioSolutions Inc. Q3 FY2021 Earnings Call ·

Affiliation history

Company network

Leadership on record at Emergent BioSolutions Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Emergent BioSolutions Inc. (EBS) $557,966 $2,010,487
2022 Emergent BioSolutions Inc. (EBS) $574,846 $3,621,626
2021 Emergent BioSolutions Inc. (EBS) $574,270 $2,092,783
2020 Emergent BioSolutions Inc. (EBS) $546,507 $2,175,528
2019 Emergent BioSolutions Inc. (EBS) $484,120 $1,845,367
2018 Emergent BioSolutions Inc. (EBS) $480,728 $1,659,081
2017 Emergent BioSolutions Inc. (EBS) $448,842 $1,158,295

Recent activity